QQ客服 官方微博 反馈留言

	Dual trigger of triptorelin and HCG optimizes clinical outcome for high ovarian responder in GnRH-antagonist protocols
	Li, Saijiao; Zhou, Danni; Yin, Tailang; Xu, Wangming; Xie, Qingzhen; Cheng, Dan; Yang, Jing
刊名	ONCOTARGET
	2018
卷号	9期号:4
关键词	dual trigger GnRH agonist GnRH antagonist protocols OHSS high ovarian response
ISSN号	1949-2553
DOI	10.18632/oncotarget.23916
URL标识	查看原文
收录类别	SCIE
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4053305
专题	武汉大学
推荐引用方式 GB/T 7714	Li, Saijiao,Zhou, Danni,Yin, Tailang,et al. Dual trigger of triptorelin and HCG optimizes clinical outcome for high ovarian responder in GnRH-antagonist protocols[J]. ONCOTARGET,2018,9(4).
APA	Li, Saijiao.,Zhou, Danni.,Yin, Tailang.,Xu, Wangming.,Xie, Qingzhen.,...&Yang, Jing.(2018).Dual trigger of triptorelin and HCG optimizes clinical outcome for high ovarian responder in GnRH-antagonist protocols.ONCOTARGET,9(4).
MLA	Li, Saijiao,et al."Dual trigger of triptorelin and HCG optimizes clinical outcome for high ovarian responder in GnRH-antagonist protocols".ONCOTARGET 9.4(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。